# Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

> **NCT07673822** · — · ENROLLING_BY_INVITATION · sponsor: **Novo Nordisk A/S** · enrollment: 800000 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Obesity
- Chronic Kidney Disease
- Cardiovascular Risk

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT07673822
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-06-08
- **Primary completion:** 2026-08-03
- **Final completion:** 2026-08-03
- **Target enrollment:** 800000 (ESTIMATED)
- **Last updated:** 2026-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07673822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07673822, "Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07673822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
